Table 3.
Within-group 5-year change from baseline β (95% CI); p-value | P for trend | Between-group difference | ||
---|---|---|---|---|
Unadjusted model β (95% CI); p-valuec | Adjusted modelb β (95% CI); p-valuec | |||
Outcome: SPPB score (0–12) | ||||
Nutritional deficits | <0.001 | |||
No deficit, | −0.43 (−0.86, 0.01); 0.057 | Ref. | Ref. | |
1 deficit, | −0.47 (−0.84, −0.11); 0.011 | −0.05 (−0.62, 0.52); 0.871 | −0.03 (−0.59, 0.53); 0.921 | |
≥2 deficits) | −0.80 (−1.17, −0.42); <0.001 | −0.37 (−0.95, 0.20); 0.411 | −0.23 (−0.80, 0.33); 0.843 | |
Outcome: gait speed (m/s) | ||||
Nutritional deficits | <0.001 | |||
No deficit, | −0.09 (−0.16, −0.02); 0.010 | Ref. | Ref. | |
1 deficit, | −0.05 (−0.11, 0.01); 0.052 | 0.03 (−0.05, 0.12); 0.879 | 0.03 (−0.06, 0.11); 0.813 | |
≥2 deficits) | −0.08 (−0.14, −0.03); 0.005 | 0.01 (−0.08, 0.09); 0.879 | −0.01 (−0.10, 0.08); 0.813 | |
Outcome: chair rise time (s) | ||||
Nutritional deficits | <0.001 | |||
No deficit, | 0.77 (−0.08, 1.62); 0.075 | Ref. | Ref. | |
1 deficit, | 0.46 (−0.24, 1.17); 0.198 | −0.31 (−1.41, 0.80); 0.585 | −0.18 (−1.26, 0.90); 0.739 | |
≥2 deficits) | 1.13 (0.39, 1.86); 0.003 | 0.36 (−0.77, 1.48); 0.585 | 0.40 (−0.71, 1.50); 0.739 |
CI, confidence interval; Ref, reference group; SPPB, Short Physical Performance Battery.
Cutoff of nutritional deficits: vitamin D <20 ng/ml, homocysteine >14 μmol/L, omega-3 index ≤ lower quartile (≤4.87%).
Adjustments for age, sex, Multidomain Alzheimer Preventive Trial (MAPT) groups, education, body mass index, physical activity status, and time interactions.
P-value adjusted for multiple comparisons using the Benjamini-Hochberg procedure.